结论：赛尼哌用于肾移植的免疫诱导治疗，可以预防和减少急性排斥反应的发生，安全性和耐受性好。
CONCLUSION: Zenapax used for immunity induction of renal transplantation can prevent and reduce the occurrence of acute reject reaction, it has safety and good tolerance.
结论HCV感染可抑制肾移植患者的细胞免疫功能，但不影响患者感染及急性排斥反应的发生率。
Conclusions HCV infection can suppress host cell immune function, but doesn't affect the rates of acute rejections and infections.
免疫荧光镜下示肾移植后急性肾小管间质性排斥反应。 免疫沉积物出现在肾小球间。
The immunofluorescence pattern with acute tubulointerstitial renal transplant rejection is shown here, in which immune deposits occur between glomeruli in the interstitium.
应用推荐